• Site Map
  • PDF
  • Subscription
  • Register
  • LogIn
  • Site Map
  • PDF
  • Subscription
  • Register
  • LogIn
Biz & Tech
  • Automotive
  • IT
  • Game
  • Heavy industries
  • Light industries
  • Science
  • Photo News
Thu, February 21, 2019 | 20:11
      • North Korea
      • Entertainment
        • Hallyu
        • Music
        • Dramas & TV shows
        • Movies
        • Performances
        • Exhibitions
      • Opinion
        • Editorial
        • Columnists
          • Park Moo-jong
          • Choi Sung-jin
          • Mark Peterson
          • Troy Stangarone
          • Tong Kim
          • Lee Seong-hyon
          • Andrew Salmon
          • John Burton
          • Jason Lim
          • Donald Kirk
          • Kim Ji-myung
          • Michael Breen
          • Hyon O'Brien
          • Younghoy Kim Kimaro
          • Deauwand Myers
          • Bernard Rowan
          • Casey Lartigue, Jr.
          • Stephen Costello
          • Semoon Chang
          • Korean Historical Sense
        • Reporter's Notebook
        • Blogs
        • Guest Column
        • Thoughts of the Times
        • Letter to the Editor
        • Times Forum
        • Cartoon
        • Today in History
      • Economy
        • Policies
        • Finance
        • Photo News
      • Biz & Tech
        • Automotive
        • IT
        • Game
        • Heavy industries
        • Light industries
        • Science
        • Photo News
      • National
        • Politics
        • Foreign Affairs
        • Defense Affairs
        • Labor & environment
        • Investigations
        • Seoul & provinces
        • Diseases & welfare
        • Foreign Communities
        • Easy Korean
        • Embassy News
        • Education
        • Obituaries
        • Photo News
      • Culture
        • Books
        • Hotel & Travel
        • Fashion
        • Food
        • Fortune Telling
        • Religions
        • Korean Traditions
        • Trend
        • Healthcare
      • Sports
        • Football
        • Golf
        • Baseball
        • Other Sports
      • World
        • Asia Pacific
        • Americas
        • Other Regions
        • SCMP
      • Video
        • News
        • Feature
        • On the spot
      • Photos
      • Community
        • Time Forum
        • Market Place
        • Study Plaza
        • Talk Box
      • Learning English
    Science
    Green Cross, Hanmi to seek investors for drug development
    Posted : 2018-01-04 15:41
    Updated : 2018-01-04 19:00
    Jeff Stute, global head of healthcare investment banking at J.P. Morgan, delivers a speech at J.P. Morgan Healthcare Conference in January, 2017. / Courtesy of J.P. Morgan

    By Park Hyong-ki

    Local biopharmaceutical companies are mobilizing their executive and research teams to take part in the biggest healthcare conference hosted by J.P. Morgan in San Francisco, California next week.

    They will be introducing their research and development (R&D) projects in the pipeline this year to attract global investors to further the development and commercialization of new medicines for overseas markets.

    Green Cross, the listed flu vaccine giant, said it will be attending the J.P. Morgan Healthcare Conference again this week, following in January last year.

    But rather than presenting its case in a session, its team will mostly be meeting potential investors and partners on the sidelines for networking.

    The company has numerous ongoing projects to develop drugs for the treatment of diseases related to blood and immune system enhancement that need more time and capital to make them available not only locally but also worldwide.

    Green Cross has recently abbreviated its corporate name to GC as it seeks to start afresh with a focus on foraying into global markets.

    "Besides Samsung BioLogics and Celltrion, local companies' operations and sales had mostly been domestically focused," a GC spokesman said.

    "The industry is just starting to look overseas for more opportunities."

    GC is planning to manufacture biotherapeutic drugs for the treatment of diseases related to the immune and circulatory systems in Canada beginning in 2020, it noted.

    GC Holdings has a 50 percent stake in GC, whose other key shareholders include the National Pension Service and Matthews International Capital Management, a U.S. investment fund.

    Like GC, an increasing number of companies here are adopting an open innovation model where they can develop drugs using external assistance from scientists and entrepreneurs beyond borders.

    Such a model has been widely used by global giants such as Merck and Pfizer.

    In Korea, the model is helping local companies to focus more on R&D of original consumer drugs, while moving away from producing generic ones, Hanmi Pharmaceutical said in its audit report.

    The value of the local pharmaceutical market stood at around 21.7 trillion won last year, according to the Ministry of Food and Drug Safety.

    However, about 80 percent of it came from prescription drugs from doctors and pharmacists.

    This structure has only enabled drug companies to market their products to hospitals, and less directly to consumers.

    The R&D of new drugs through the model is helping to reshape this aging business landscape.

    Hanmi also has numerous projects to develop biotherapeutic drugs for the treatment of obesity and diabetes, some of which could be presented to investors at the conference.

    Although Hanmi would not disclose details, it said meetings with potential investors will likely follow its formal presentation of its plan for this year.

    Hanmi Chairman and founder Lim Sung-ki has a 34.23 percent in Hanmi Science, which holds a majority stake in Hanmi Pharmaceutical.

    It has formed partnerships with Sanofi and Janssen.

    The conference's keynote speakers will include Bill Gates, the founder of Microsoft and co-chair of the Bill & Melinda Gates Foundation, and Jamie Dimon, chairman & CEO of JPMorgan Chase.


    hyongki@ktimes.com More articles by this reporter



     
    • 'Shortage of nurses creates bullying culture'
    • US soldier relieved by Korean's recovery from Grand Canyon fall
    • Lawmaker proposes bill to ban smoking while walking
    • Hyundai Motor overwhelmed by soaring Palisade orders
    • Abe gets no answer from North Korea
    • Seoul pushing inter-Korean projects as summit agenda
    • Family demands truth behind Korean man's mystery death in Indonesia
    • South Korean president touts stronger tie with India
    • Trump says he expects 'great progress' at 2nd summit with Kim
    • North Korea envoy separated from his daughter, says defector
    • Exhibition pays tribute to independence fighters
    • Wanna One's Yoon Ji-sung poised to make solo debut
    • 'TWICE working to return in April,' says JYP
    • Seungri may face police questioning
    • Hero cyclist back in spotlight in film
    • No need for winter coats

    • Regretting Abe?

    • KB in Hanoi

    • Helping Myanmar children

    • Attracting investment for startups

    • Rolls-Royce CEO in Seoul

    • Celebrating Korea-Czech relations

    • To-be-built dormitory

    Cobra Gold 2019
    • About Korea Times
    • CEO Message
    • Times History
    • Contents Distribution
    • Media Kit
    • Contact Us
    • Location
    • Privacy Statement
    • Ombudsman
    • Mobile Service
    • PDF Service
    • RSS Service